PAMAM-Calix-Dendrimers: Third Generation Synthesis and Impact of Generation and Macrocyclic Core Conformation on Hemotoxicity and Calf Thymus DNA Binding
Pharmaceutics · 27.10.2024 · 16 (11) · 1379
DOI: 10.3390/pharmaceutics16111379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 27.10.2024. Verfasst von Olga Mostovaya und 13 weiteren Autor:innen. Beteiligte Einrichtung: A.M. Butlerov Chemical Institute, Kazan Federal University, Kremlevskaya, 18, 420008 Kazan, Russia. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Background/Objectives: Current promising treatments for many diseases are based on the use of therapeutic nucleic acids, including DNA. However, the list of nanocarriers is limited due to their low biocompatibility, high cost, and toxicity. The design of synthetic building blocks for creating universal delivery systems for genetic material is an unsolved problem. In this work, we propose PAMAM dendrimers with rigid thiacalixarene core in various conformations, i.e., PAMAM-calix-dendrimers, as a platform for a supramolecular universal constructor for nanomedicine.
Results
Third generation PAMAM dendrimers with a macrocyclic core in three conformations (cone, partial cone, and 1,3-alternate) were synthesized for the first time. The obtained dendrimers were capable of binding and compacting calf thymus DNA, whereby the binding efficiency improved with increasing generation, while the influence of the macrocyclic core was reduced. A dramatic effect of the macrocyclic core conformation on the hemolytic activity of PAMAM-calix-dendrimers was observed. Specifically, a notable reduction in hemotoxicity was associated with a decrease in compound amphiphilicity.
Conclusions
We hope the results will help reduce financial and labor costs in developing new drug delivery systems based on dendrimers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- A.M. Butlerov Chemical Institute, Kazan Federal University, Kremlevskaya, 18, 420008 Kazan, Russia.
- Institute of Biophysics and Cell Engineering of NASB, 27 Akademicheskaya St., 220072 Minsk, Belarus.
- State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, College of Biological Science and Medical Engineering,…
- CQM-Centro de Química da Madeira, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, Portugal.
ORCID-Profile: Igor Shiabiev, Daniil Ovchinnikov, Timur Mukhametzyanov, Viktar Abashkin, Dzmitry Shcharbin, Arthur Khannanov, Marianna Kutyreva, Mingwu Shen, Xiangyang Shi, Pavel Padnya, Ivan Stoikov
Förderung
- Russian Science Foundation
Zitieren
APA
Mostovaya, O., Shiabiev, I., Ovchinnikov, D., Pysin, D., Mukhametzyanov, T., Stanavaya, A., Abashkin, V., Shcharbin, D., Khannanov, A., Kutyreva, M., Shen, M., Shi, X., Padnya, P., & Stoikov, I. (2024). PAMAM-Calix-Dendrimers: Third Generation Synthesis and Impact of Generation and Macrocyclic Core Conformation on Hemotoxicity and Calf Thymus DNA Binding. Pharmaceutics, 16(11), 1379. https://doi.org/10.3390/pharmaceutics16111379
Vancouver
Mostovaya O, Shiabiev I, Ovchinnikov D, Pysin D, Mukhametzyanov T, Stanavaya A, et al. PAMAM-Calix-Dendrimers: Third Generation Synthesis and Impact of Generation and Macrocyclic Core Conformation on Hemotoxicity and Calf Thymus DNA Binding. Pharmaceutics. 2024;16(11):1379. doi:10.3390/pharmaceutics16111379
BibTeX
@article{Mostovaya2024,
author = {Mostovaya, Olga and Shiabiev, Igor and Ovchinnikov, Daniil and Pysin, Dmitry and Mukhametzyanov, Timur and Stanavaya, Alesia and Abashkin, Viktar and Shcharbin, Dzmitry and Khannanov, Arthur and Kutyreva, Marianna and Shen, Mingwu and Shi, Xiangyang and Padnya, Pavel and Stoikov, Ivan},
title = {PAMAM-Calix-Dendrimers: Third Generation Synthesis and Impact of Generation and Macrocyclic Core Conformation on Hemotoxicity and Calf Thymus DNA Binding},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {11},
pages = {1379},
doi = {10.3390/pharmaceutics16111379}
}
EUVIMED